Document Detail


Measuring symptoms in localized prostate cancer: a systematic review of assessment instruments.
MedLine Citation:
PMID:  23381695     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
It is critical for prostate cancer researchers and clinicians to have access to comprehensive, sensitive and simple-to-use symptom measures that allow them to understand and quantify the subjective patient experience. The purpose of the current review is to provide a comprehensive review, detailed tool descriptions and objectively defined quality criteria to facilitate tool choices for patients with localized prostate cancer. Using a systematic web-based literature search, we found n=29 prostate symptom measures described in n=35 validation studies. To be recommended, tools needed to meet four criteria: broad domain coverage, ability to differentiate objective and subjective experience, good internal consistency and validation in at least two populations and/or having achieved two types of validations. Of the 29 tools reviewed, n=7 meet our criteria for recommendation, and three in particular (the EPIC-26 (Expanded Prostate Cancer Index Composite)-26, PC-QOL (Prostate Cancer-Quality of Life) and the UCLA-PCI (UCLA Prostate Cancer Index)) showed the strongest psychometrics. There is a reasonable number of measures to choose from that meet criteria for good psychometrics.Prostate Cancer and Prostatic Disease advance online publication, 5 February 2013; doi:10.1038/pcan.2013.1.
Authors:
K Rnic; W Linden; I Tudor; R Pullmer; A Vodermaier
Related Documents :
23840365 - The mpo-463g>a polymorphism and lung cancer risk: a meta-analysis based on 22 case-cont...
24524195 - "not a nice experience, not at all": underprivileged women's experiences of being confr...
24783175 - The prognosis and treatment of primary thyroid cancer occurred in breast cancer patient...
22993025 - Systematic review of oral cryotherapy for management of oral mucositis caused by cancer...
17308075 - An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer.
19142185 - Immunochemical faecal occult blood test: number of samples and positivity cutoff. what ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-05
Journal Detail:
Title:  Prostate cancer and prostatic diseases     Volume:  -     ISSN:  1476-5608     ISO Abbreviation:  Prostate Cancer Prostatic Dis.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815755     Medline TA:  Prostate Cancer Prostatic Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Psychology, University of British Columbia, Vancouver, BC, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients w...
Next Document:  Food intake and anthropometric evaluation in school-aged children of Buenos Aires.